Bojarska-Junak A - Search Results

1

Prognostic Potential of Galectin-9 mRNA Expression in Chronic Lymphocytic Leukemia.

Bojarska-Junak A, Kowalska W, Chocholska S, Szymańska A, Tomczak W, Zarobkiewicz MK, Roliński J. Bojarska-Junak A, et al. Cancers (Basel). 2023 Nov 11;15(22):5370. doi: 10.3390/cancers15225370. Cancers (Basel). 2023. PMID: 38001630 Free PMC article.

2

[Serum TGF-beta1 level in children with reflux nephropathy].

Zajaczkowska M, Bieniaś B, Borzecka H, Sikora P, Majewski M, Bojarska-Junak A. Zajaczkowska M, et al. Przegl Lek. 2006;63 Suppl 3:121-3. Przegl Lek. 2006. PMID: 16898507 Polish.

3

[CD43 in B-cell chronic lymphocytic leukemia].

Roliński J, Rupniewska ZM, Dmoszyńska A, Wasik-Szczepanek E, Bojarska-Junak A. Roliński J, et al. Pol Arch Med Wewn. 1999 Sep;102(3):753-62. Pol Arch Med Wewn. 1999. PMID: 10949882 Review. Polish.

4

Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients.

Dmoszyńska A, Roliński J, Bojarska-Junak A, Mańko J, Jawniak D, Walter-Croneck A, Soroka-Wojtaszko M, Hus M. Dmoszyńska A, et al. Pol J Pharmacol. 2001 Nov-Dec;53(6):709-13. Pol J Pharmacol. 2001. PMID: 11985351 Free article.

5

Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma.

Dmoszyńska A, Bojarska-Junak A, Domański D, Roliński J, Hus M, Soroka-Wojtaszko M. Dmoszyńska A, et al. Leuk Lymphoma. 2002 Feb;43(2):401-6. doi: 10.1080/10428190290006224. Leuk Lymphoma. 2002. PMID: 11999576

6

Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.

Bojarska-Junak A, Rolinski J, Wasik-Szczepaneko E, Kaluzny Z, Dmoszynska A. Bojarska-Junak A, et al. Haematologica. 2002 May;87(5):490-9. Haematologica. 2002. PMID: 12010662

7

Evaluation of myeloid and lymphoid dendritic cells in peritoneal fluid in women with non-malignant ovarian tumors.

Wertel I, Kotarski J, Roliński J, Bojarska-Junak A, Gogacz M. Wertel I, et al. Am J Reprod Immunol. 2003 Sep;50(3):238-42. doi: 10.1034/j.1600-0897.2003.00081.x. Am J Reprod Immunol. 2003. PMID: 14629029

8

The influence of thalidomide therapy on cytokine secretion, immunophenotype, BCL-2 expression and microvessel density in patients with resistant or relapsed multiple myeloma.

Dmoszynska A, Podhorecka M, Manko J, Bojarska-Junak A, Rolinski J, Skomra D. Dmoszynska A, et al. Neoplasma. 2005;52(2):175-81. Neoplasma. 2005. PMID: 15800717 Clinical Trial.

9

Modification of immunocytochemical ZAP-70 assay for potential clinical application in B-cell chronic lymphocytic leukemia.

Bojarska-Junak A, Roliński J, Kawiak J. Bojarska-Junak A, et al. Folia Histochem Cytobiol. 2005;43(1):19-23. Folia Histochem Cytobiol. 2005. PMID: 15871558

10

Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals.

Gumieniczek A, Hopkała H, Roliński J, Bojarska-Junak A. Gumieniczek A, et al. Pharmacol Res. 2005 Aug;52(2):162-6. doi: 10.1016/j.phrs.2005.02.019. Pharmacol Res. 2005. PMID: 15967382

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page